新型冠状病毒肺炎相关肝损伤研究进展  

Research advances in coronavirus disease 2019-related liver injury

作　　者：崔浩 梁静[1,2] 向慧玲 CUI Hao;LIANG Jing;XIANG Huiling(The Third Central Clinical College of Tianjin Medical University,Tianjin 300170,China;Department of Hepatology,Tianjin Third Central Hospital,Tianjin 300170,China)

机构地区：[1]天津医科大学三中心临床学院,天津300170 [2]天津市第三中心医院消化肝病科,天津300170

出　　处：《临床肝胆病杂志》2022年第4期931-935,共5页Journal of Clinical Hepatology

基　　金：天津科技重大专项与工程重大疾病防治(19ZXDBSY00030)。

摘　　要：新型冠状病毒肺炎的大流行对全球的公共卫生安全造成了巨大威胁及挑战,并改变了医疗配置的优先性。在新型冠状病毒肺炎的临床诊治中,可以观察到相当比例的患者发生肝损伤,尤其是重症或危重症患者。本文总结新型冠状病毒肺炎致肝损伤的流行病学、机制、临床特征及治疗,希望可对临床医生的决策和优化治疗提供帮助。The coronavirus disease 2019(COVID-19)pandemic has brought great threats and challenges to global public health and has changed the priorities of medical resource allocation.A considerable proportion of patients with liver injury is observed during the clinical diagnosis and treatment of COVID-19,especially in those with a severe or critical illness.This article summarizes the epidemiology,mechanism,clinical features,and treatment of liver injury caused by COVID-19,in order to help clinicians with decision making and treatment optimization.

关 键 词：新型冠状病毒肺炎 肝功能不全 药物性肝损伤 治疗学 

分 类 号：R563.1[医药卫生—呼吸系统] R575[医药卫生—内科学]